跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Can AI Discover New Drugs? A High-Level Overview

1Why Drug Discovery Is Hard, and Where AI Fits2How AI Learns From Molecules and Proteins3Finding and Validating a Biological Target4Designing Molecules: Generative AI and Virtual Screening5From Hit to Lead: Optimizing Properties With AI6What AI Still Cannot Do7Judging the Claims: Real Successes, Failures, and Open Questions
Why Drug Discovery Is Hard, and Where AI Fits

Where AI Actually Enters the Pipeline

4 / 4
Here the same pipeline is drawn again, but now three stages carry an AI marker. At target selection, AI's role is prioritization: it ranks which proteins are most likely to matter. At hit finding, its role is filtering: it narrows a large compound library down to a testable set. At lead optimization, its role is property prediction: it estimates how a compound will behave so chemists know what to make. Follow the arrow downward and notice where the markers stop — nothing is marked at preclinical testing or the three trial phases. That gap is the point. AI proposes which experiments are worth running; it does not prove what happens in a patient.
0:00 / 0:00

AI is not a single tool applied at a single point. It appears at several distinct stages, and at each one it plays a different role.

At target selection, AI is used to integrate many kinds of evidence — genetic association data, scientific literature, and measurements of gene activity in diseased tissue — to rank which proteins are most likely to be causally involved in a disease. The role here is prioritization: narrowing a long list of plausible targets to a shorter one worth investigating.

At hit finding, AI is used to predict which compounds in a large library are likely to interact with the chosen target, so that laboratory testing can focus on the most promising candidates. This is called virtual screening, and its role is filtering.

At lead optimization, AI predicts properties such as how quickly the body will break the compound down or whether it is likely to be toxic, allowing chemists to choose which variants to synthesize. The role here is prediction of properties that are expensive to measure directly.

In each case the pattern is the same: AI does not replace the experiment. It decides which experiments are worth running. That distinction — proposal versus proof — will matter throughout this course.

参考资料

  1. [1]Artificial intelligence for drug discovery: resources, methods, and applicationsncbi.nlm.nih.gov
上一页4 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion